COCP READ THE FULL COCP RESEARCH REPORT Business Update Phase 1b Challenge Study of CDI-922 to be Initiated in 1H26 Cocrystal Pharma, Inc. (NASDAQ:COCP) is developing CDI-988 as a prophylaxis and ...

First, the phase 3 trial of Moderna’s norovirus vaccine had to endure a clinical hold. | First, the phase 3 trial of ...

Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...

Entered into an exclusive license agreement with Dynavax for the Company’s COVID-19 oral pill vaccine candidate for potential cumulative proceeds ...

Q3 2025 Earnings Call Transcript November 13, 2025 Vaxart, Inc. beats earnings expectations. Reported EPS is $-0.04, ...

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected ...

We expect to begin enrolling participants in the first quarter of 2026 for our norovirus challenge study evaluating CDI-988, our oral ...

Many hungry travelers turn to airport grab-and-go food before flights, but if you want to avoid getting sick before hopping ...

Six people have died due to an outbreak of listeria linked to prepared pasta meals sold at major US grocery chains. A doctor ...

On a cross-country road trip, a stop at a fast-food eatery is convenient and budget-friendly, but you should try to avoid ...

Moderna reported third-quarter financial results on Thursday. The transcript from the company's earnings call has been provided below.